Cargando…

Deviations in human gut microbiota: a novel diagnostic test for determining dysbiosis in patients with IBS or IBD

BACKGROUND: Dysbiosis is associated with many diseases, including irritable bowel syndrome (IBS), inflammatory bowel diseases (IBD), obesity and diabetes. Potential clinical impact of imbalance in the intestinal microbiota suggests need for new standardised diagnostic methods to facilitate microbiom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Casén, C., Vebø, H. C., Sekelja, M., Hegge, F. T., Karlsson, M. K., Ciemniejewska, E., Dzankovic, S., Frøyland, C., Nestestog, R., Engstrand, L., Munkholm, P., Nielsen, O. H., Rogler, G., Simrén, M., Öhman, L., Vatn, M. H., Rudi, K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2015
Materias:	Deviations in Human Gut Microbiota
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5029765/ https://www.ncbi.nlm.nih.gov/pubmed/25973666 http://dx.doi.org/10.1111/apt.13236

Ejemplares similares

Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD
por: Sabino, João, et al.
Publicado: (2016)

Deviated and early unsustainable stunted development of gut microbiota in children with autism spectrum disorder
por: Lou, Mingxing, et al.
Publicado: (2022)

No distinct microbiome signature of irritable bowel syndrome found in a Swedish random population
por: Hugerth, Luisa W, et al.
Publicado: (2020)

Bacteriophage transfer during faecal microbiota transplantation in Clostridium difficile infection is associated with treatment outcome
por: Zuo, Tao, et al.
Publicado: (2018)

Spatial variation of the colonic microbiota in patients with ulcerative colitis and control volunteers
por: Lavelle, A, et al.
Publicado: (2015)

The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia
por: Schuijt, Tim J, et al.
Publicado: (2016)

Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit time
por: de Groot, Pieter, et al.
Publicado: (2020)

Duodenal Anaerobutyricum soehngenii infusion stimulates GLP-1 production, ameliorates glycaemic control and beneficially shapes the duodenal transcriptome in metabolic syndrome subjects: a randomised double-blind placebo-controlled cross-over study
por: Koopen, Annefleur, et al.
Publicado: (2022)

Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent Clostridioides difficile infection
por: Mullish, Benjamin H, et al.
Publicado: (2019)

International Cancer Microbiome Consortium consensus statement on the role of the human microbiome in carcinogenesis
por: Scott, Alasdair J, et al.
Publicado: (2019)

Commensal bacteria drive endogenous transformation and tumour stem cell marker expression through a bystander effect
por: Wang, Xingmin, et al.
Publicado: (2015)

Structural robustness of the gut mucosal microbiota is associated with Crohn's disease remission after surgery
por: Mondot, S, et al.
Publicado: (2016)

Roseburia intestinalis generated butyrate boosts anti-PD-1 efficacy in colorectal cancer by activating cytotoxic CD8(+) T cells
por: Kang, Xing, et al.
Publicado: (2023)

Intestinal microbiota is altered in patients with colon cancer and modified by probiotic intervention
por: Hibberd, Ashley A, et al.
Publicado: (2017)

Targeting the gut microbiota with inulin-type fructans: preclinical demonstration of a novel approach in the management of endothelial dysfunction
por: Catry, Emilie, et al.
Publicado: (2018)

Discovery of the gut microbial signature driving the efficacy of prebiotic intervention in obese patients
por: Rodriguez, Julie, et al.
Publicado: (2020)

Gut microbiota of obese subjects with Prader-Willi syndrome is linked to metabolic health
por: Olsson, Lisa M, et al.
Publicado: (2020)

Postinfective bowel dysfunction following Campylobacter enteritis is characterised by reduced microbiota diversity and impaired microbiota recovery
por: Jalanka, Jonna, et al.
Publicado: (2023)

Hepatocyte MyD88 affects bile acids, gut microbiota and metabolome contributing to regulate glucose and lipid metabolism
por: Duparc, Thibaut, et al.
Publicado: (2017)

A mechanism by which gut microbiota elevates permeability and inflammation in obese/diabetic mice and human gut
por: Mishra, Sidharth P, et al.
Publicado: (2023)

Anal gas evacuation and colonic microbiota in patients with flatulence: effect of diet
por: Manichanh, Chaysavanh, et al.
Publicado: (2014)

Proton pump inhibitors alter the composition of the gut microbiota
por: Jackson, Matthew A, et al.
Publicado: (2016)

A novel faecal Lachnoclostridium marker for the non-invasive diagnosis of colorectal adenoma and cancer
por: Liang, Jessie Qiaoyi, et al.
Publicado: (2020)

Tumour-associated and non-tumour-associated microbiota in colorectal cancer
por: Flemer, Burkhardt, et al.
Publicado: (2017)

Maternal low-dose aspartame and stevia consumption with an obesogenic diet alters metabolism, gut microbiota and mesolimbic reward system in rat dams and their offspring
por: Nettleton, Jodi E, et al.
Publicado: (2020)

Scientific frontiers in faecal microbiota transplantation: joint document of Asia-Pacific Association of Gastroenterology (APAGE) and Asia-Pacific Society for Digestive Endoscopy (APSDE)
por: Ng, Siew C, et al.
Publicado: (2020)

Gut mucosal virome alterations in ulcerative colitis
por: Zuo, Tao, et al.
Publicado: (2019)

Identification of TMAO-producer phenotype and host–diet–gut dysbiosis by carnitine challenge test in human and germ-free mice
por: Wu, Wei-Kai, et al.
Publicado: (2019)

Long-term instability of the intestinal microbiome is associated with metabolic liver disease, low microbiota diversity, diabetes mellitus and impaired exocrine pancreatic function
por: Frost, Fabian, et al.
Publicado: (2021)

Gut microbiota disturbance during antibiotic therapy: a multi-omic approach
por: Pérez-Cobas, Ana Elena, et al.
Publicado: (2013)

Acute appendicitis is associated with appendiceal microbiome changes including elevated Campylobacter jejuni levels
por: Oh, Sun Jung, et al.
Publicado: (2020)

Blue poo: impact of gut transit time on the gut microbiome using a novel marker
por: Asnicar, Francesco, et al.
Publicado: (2021)

Proton pump inhibitors affect the gut microbiome
por: Imhann, Floris, et al.
Publicado: (2016)

Dysosmobacter welbionis is a newly isolated human commensal bacterium preventing diet-induced obesity and metabolic disorders in mice
por: Le Roy, Tiphaine, et al.
Publicado: (2022)

Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19
por: Yeoh, Yun Kit, et al.
Publicado: (2021)

Dietary supplementation with inulin-propionate ester or inulin improves insulin sensitivity in adults with overweight and obesity with distinct effects on the gut microbiota, plasma metabolome and systemic inflammatory responses: a randomised cross-over trial
por: Chambers, Edward S, et al.
Publicado: (2019)

Antibiotics-induced monodominance of a novel gut bacterial order
por: Hildebrand, Falk, et al.
Publicado: (2019)

Obesity-associated deficits in inhibitory control are phenocopied to mice through gut microbiota changes in one-carbon and aromatic amino acids metabolic pathways
por: Arnoriaga-Rodríguez, María, et al.
Publicado: (2021)

Whole grain-rich diet reduces body weight and systemic low-grade inflammation without inducing major changes of the gut microbiome: a randomised cross-over trial
por: Roager, Henrik Munch, et al.
Publicado: (2019)

Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota
por: Serino, Matteo, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_b4v9no6cvrsrrqsbq3idbke5gg